Prohost Biotech On
Under the title “Halozyme has Good News and Array Too”, we wrote the following about Array On Nov. 5, 2015.
Array’s (ARRY) internal, broad based drug discovery and research technological capabilities is behind the creation of its small molecule therapeutics. Array’s know-how and expertise led it to build a library of therapeutics for advanced cancers and other diseases. Array’s library’s therapeutic molecules are expected to be picked and used when sequencing of tumors’ genomes points to one, or a combination . . .